19,922
Total Claims
$1.1M
Drug Cost
1,362
Beneficiaries
$804
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-47%
Cost per patient vs peers
$804 vs $1,524 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 18,411 claims · $218K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 403 | $247K |
| Dapagliflozin Propanediol | 269 | $169K |
| Mavacamten | 16 | $130K |
| Evolocumab | 190 | $106K |
| Rivaroxaban | 150 | $96K |
| Ticagrelor | 149 | $74K |
| Omega-3 Acid Ethyl Esters | 820 | $42K |
| Evolocumab | 51 | $29K |
| Atorvastatin Calcium | 2,128 | $16K |
| Losartan Potassium | 1,529 | $15K |
| Metoprolol Succinate | 1,253 | $14K |
| Ranolazine | 190 | $11K |
| Sacubitril/Valsartan | 11 | $9,507 |
| Ezetimibe | 847 | $9,473 |
| Losartan/Hydrochlorothiazide | 562 | $8,875 |
Prescribing Profile
67
Unique Drugs
$520K
Patient Profile
73
Avg Age
53%
Female
2.15
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data